Findings from large systematic review may have implications for future ART guidelines

Results from a large systematic review of first-line combination antiretroviral therapy (ART) in people living with HIV (PLHIV) have confirmed that the type of nucleoside reverse transcriptase inhibitor (NRTI) backbone, type of third agent, and higher baseline CD4 lymphocyte counts, are independently predictive of greater efficacy at week 48.1